1. Home
  2. WSO vs ASND Comparison

WSO vs ASND Comparison

Compare WSO & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Watsco Inc.

WSO

Watsco Inc.

HOLD

Current Price

$387.39

Market Cap

14.9B

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$267.20

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSO
ASND
Founded
1945
2006
Country
United States
Denmark
Employees
7050
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9B
15.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
WSO
ASND
Price
$387.39
$267.20
Analyst Decision
Hold
Strong Buy
Analyst Count
6
16
Target Price
$399.00
$281.50
AVG Volume (30 Days)
312.3K
704.2K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
3.08%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.02
$96.35
Revenue Next Year
$5.20
$44.91
P/E Ratio
$34.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$323.05
$161.09
52 Week High
$494.94
$282.15

Technical Indicators

Market Signals
Indicator
WSO
ASND
Relative Strength Index (RSI) 46.33 61.67
Support Level $355.11 $213.28
Resistance Level $388.96 N/A
Average True Range (ATR) 11.32 9.98
MACD -1.38 -0.15
Stochastic Oscillator 25.48 68.05

Price Performance

Historical Comparison
WSO
ASND

About WSO Watsco Inc.

Watsco is the largest HVAC and refrigeration products distributor in North America with approximately 13% market share. The company primarily operates in the United States (90% of revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada, Latin America, and the Caribbean. The company's customer base comprises more than 120,000 dealers and contractors serving the replacement and new-construction HVAC/R markets for residential and light-commercial applications. As much as 20% of residential HVAC units are distributed through Watsco in any given year. Revenue is approximately 75%-80% residential HVAC and 20%-25% commercial, with relatively small exposure to more complex "applied" solutions.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: